Cystic Fibrosis: Management
Cystic Fibrosis: Pathogenesis
Drugs for Treatment of Constipation-Predominant IBS
Gastrointestinal Motility Disorders
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Inflammatory Bowel Disease V: Surgical Management
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Steven D Freedman1, Michael Wilschanski2, Sarah Jane Schwarzenberg3
1Co-Director, DIGEST (Developing Innovative Gastrointestinal Specialty Training) Program funded through the U.S. Cystic Fibrosis Foundation, United States; Division of Translational Research and The Pancreas Center, Beth Israel Deaconess Medical Center, Boston, MA, United States; Boston Children's Hospital, Division of Respiratory Diseases | Cystic Fibrosis Center, Boston, MA, United States.
No abstract available in PubMed .
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018